Medicale CORP. (MCLE) — SEC Filings
Latest SEC filings for Medicale CORP.. Recent 10-Q filing on Aug 15, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.
View Medicale CORP. on SEC EDGAR
Overview
Medicale CORP. (MCLE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Aug 15, 2025: Medicale Corp. filed its 10-Q for the period ending June 30, 2025. The company, incorporated in Nevada, operates in the health services sector. Its principal executive offices are located in Wellington, Florida. The filing covers financial information for the quarter and year-to-date periods.
Sentiment Summary
Across 10 filings, the sentiment breakdown is: 10 neutral. The dominant filing sentiment for Medicale CORP. is neutral.
Filing Type Overview
Medicale CORP. (MCLE) has filed 6 10-Q, 1 10-Q/A, 2 10-K, 1 8-K with the SEC between Jan 2024 to Aug 2025.
Filings by Year
Recent Filings (10)
-
Medicale Corp. Files 10-Q for June 2025 Quarter
— 10-Q · Aug 15, 2025 Risk: low
Medicale Corp. filed its 10-Q for the period ending June 30, 2025. The company, incorporated in Nevada, operates in the health services sector. Its principal ex -
Medicale Corp. Files Q1 2025 10-Q
— 10-Q · May 15, 2025 Risk: low
Medicale Corp. filed its 10-Q for the period ending March 31, 2025. The company, incorporated in Nevada, operates in health services and is headquartered in Wel -
Medicale Corp. Files 10-Q Amendment
— 10-Q/A · Feb 20, 2025 Risk: low
Medicale Corp. filed an amended 10-Q for the period ending December 31, 2024, on February 20, 2025. The filing indicates corrections to typos and other edits wi -
Medicale Corp. Files 10-Q for Q4 2024
— 10-Q · Feb 18, 2025 Risk: low
Medicale Corp. filed its 10-Q for the period ending December 31, 2024. The filing covers the fourth quarter and fiscal year. Specific financial details and oper -
Medicale Corp. Files 2024 Annual Report
— 10-K · Jan 14, 2025 Risk: low
Medicale Corp. filed its 10-K for the fiscal year ending September 30, 2024, reporting on its operations in health services. The company, incorporated in Nevada -
Medicale Corp. Files 8-K for Accountant Change & Financials
— 8-K · Dec 31, 2024 Risk: low
Medicale Corp. filed an 8-K on December 31, 2024, to report changes in its certifying accountant and to file financial statements and exhibits. The company, inc -
Medicale Corp. Files Q2 2024 10-Q
— 10-Q · Aug 15, 2024 Risk: low
Medicale Corp. filed its quarterly report on Form 10-Q for the period ending June 30, 2024. The company, incorporated in Nevada, operates in the health services -
Medicale Corp. Files 10-Q for Period Ending March 31, 2024
— 10-Q · May 14, 2024 Risk: low
Medicale Corp. (MCLE) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Medicale Corp. filed a 10-Q report for the period ending March 31, 2024. The -
Medicale Corp. Files Quarterly Report for Period Ended December 31, 2023
— 10-Q · Feb 15, 2024 Risk: low
Medicale Corp. (MCLE) filed a Quarterly Report (10-Q) with the SEC on February 15, 2024. Medicale Corp. filed a Form 10-Q for the quarterly period ended Decembe -
Medicale Corp. Files 2023 Annual Report on Form 10-K
— 10-K · Jan 2, 2024 Risk: low
Medicale Corp. (MCLE) filed a Annual Report (10-K) with the SEC on January 2, 2024. Medicale Corp. filed its annual report on Form 10-K for the fiscal year ende
Risk Profile
Risk Assessment: Of MCLE's 10 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 10 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Industry Context
Medicale Corp. operates within the Health Services sector (SIC code 8000).
Top Tags
10-Q (7) · financials (3) · health-services (3) · Medicale Corp. (3) · SEC Filing (3) · quarterly-report (2) · 10-K (2) · healthcare (1) · amendment (1) · filing-correction (1)
Key Numbers
- Reporting Period End Date: 20250630 — Indicates the end of the fiscal quarter for which the report is filed.
- Filing Date: 20250815 — The date the 10-Q was officially submitted to the SEC.
- Fiscal Year End: 0930 — Company's fiscal year end
- Quarterly Period End Date: 2023-12-31 — The report is for the quarterly period ended on this date.
- Commission File Number: 333-250025 — SEC file number for Medicale Corp.
- Accession Number: 0001683168-24-000004 — Unique identifier for the filing
- Public Document Count: 49 — Number of documents in the filing
Frequently Asked Questions
What are the latest SEC filings for Medicale CORP. (MCLE)?
Medicale CORP. has 10 recent SEC filings from Jan 2024 to Aug 2025, including 6 10-Q, 2 10-K, 1 10-Q/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MCLE filings?
Across 10 filings, the sentiment breakdown is: 10 neutral. The dominant sentiment is neutral.
Where can I find Medicale CORP. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Medicale CORP. (MCLE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Medicale CORP.?
Key financial highlights from Medicale CORP.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for MCLE?
The investment thesis for MCLE includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Medicale CORP.?
Executive information for Medicale CORP. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Medicale CORP. stock?
Of MCLE's 10 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 10 low-risk.
What are recent predictions and forward guidance from Medicale CORP.?
Forward guidance and predictions for Medicale CORP. are extracted from SEC filings as they are enriched.